BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23724906)

  • 21. Missense mutation in GRN gene affecting RNA splicing and plasma progranulin level in a family affected by frontotemporal lobar degeneration.
    Luzzi S; Colleoni L; Corbetta P; Baldinelli S; Fiori C; Girelli F; Silvestrini M; Caroppo P; Giaccone G; Tagliavini F; Rossi G
    Neurobiol Aging; 2017 Jun; 54():214.e1-214.e6. PubMed ID: 28285794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neuroimaging signature of frontotemporal lobar degeneration associated with Granulin mutations: an effective connectivity study.
    Premi E; Grassi M; Gazzina S; Paghera B; Pepe D; Archetti S; Padovani A; Borroni B
    J Nucl Med; 2013 Jul; 54(7):1066-71. PubMed ID: 23687363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations.
    Van Deerlin VM; Wood EM; Moore P; Yuan W; Forman MS; Clark CM; Neumann M; Kwong LK; Trojanowski JQ; Lee VM; Grossman M
    Arch Neurol; 2007 Aug; 64(8):1148-53. PubMed ID: 17698705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease.
    Carecchio M; Fenoglio C; De Riz M; Guidi I; Comi C; Cortini F; Venturelli E; Restelli I; Cantoni C; Bresolin N; Monaco F; Scarpini E; Galimberti D
    J Neurol Sci; 2009 Dec; 287(1-2):291-3. PubMed ID: 19683260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Portuguese family with the co-occurrence of frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis phenotypes due to progranulin gene mutation.
    Almeida MR; Macário MC; Ramos L; Baldeiras I; Ribeiro MH; Santana I
    Neurobiol Aging; 2016 May; 41():200.e1-200.e5. PubMed ID: 27021778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.
    Finch N; Carrasquillo MM; Baker M; Rutherford NJ; Coppola G; Dejesus-Hernandez M; Crook R; Hunter T; Ghidoni R; Benussi L; Crook J; Finger E; Hantanpaa KJ; Karydas AM; Sengdy P; Gonzalez J; Seeley WW; Johnson N; Beach TG; Mesulam M; Forloni G; Kertesz A; Knopman DS; Uitti R; White CL; Caselli R; Lippa C; Bigio EH; Wszolek ZK; Binetti G; Mackenzie IR; Miller BL; Boeve BF; Younkin SG; Dickson DW; Petersen RC; Graff-Radford NR; Geschwind DH; Rademakers R
    Neurology; 2011 Feb; 76(5):467-74. PubMed ID: 21178100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microglia in frontotemporal lobar degeneration with progranulin or C9ORF72 mutations.
    Sakae N; Roemer SF; Bieniek KF; Murray ME; Baker MC; Kasanuki K; Graff-Radford NR; Petrucelli L; Van Blitterswijk M; Rademakers R; Dickson DW
    Ann Clin Transl Neurol; 2019 Sep; 6(9):1782-1796. PubMed ID: 31448566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation.
    Bonvicini C; Milanesi E; Pilotto A; Cattane N; Premi E; Archetti S; Padovani A; Gennarelli M; Borroni B
    Neurobiol Aging; 2014 May; 35(5):1206-11. PubMed ID: 24368088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cluster of progranulin C157KfsX97 mutations in Southern Italy: clinical characterization and genetic correlations.
    Coppola C; Saracino D; Puoti G; Lus G; Dato C; Le Ber I; Pariente J; Caroppo P; Piccoli E; Tagliavini F; Di Iorio G; Rossi G
    Neurobiol Aging; 2017 Jan; 49():219.e5-219.e13. PubMed ID: 27814992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration.
    Gibbons L; Rollinson S; Thompson JC; Robinson A; Davidson YS; Richardson A; Neary D; Pickering-Brown SM; Snowden JS; Mann DM
    Neurobiol Aging; 2015 Mar; 36(3):1603.e1-4. PubMed ID: 25435337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progranulin gene (GRN) promoter methylation is increased in patients with sporadic frontotemporal lobar degeneration.
    Galimberti D; D'Addario C; Dell'osso B; Fenoglio C; Marcone A; Cerami C; Cappa SF; Palazzo MC; Arosio B; Mari D; Maccarrone M; Bresolin N; Altamura AC; Scarpini E
    Neurol Sci; 2013 Jun; 34(6):899-903. PubMed ID: 22797721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GRN mutation in a patient with a behavioral variant of frontotemporal lobar degeneration (bvFTD).
    Walczysková S; Ressner P; Hilscherová Š; Kotlas J; Konrád J; Svobodová V
    Folia Neuropathol; 2017; 55(1):67-72. PubMed ID: 28430294
    [No Abstract]   [Full Text] [Related]  

  • 33. Structural brain signature of FTLD driven by Granulin mutation.
    Bozzali M; Battistoni V; Premi E; Alberici A; Giulietti G; Archetti S; Turla M; Gasparotti R; Cercignani M; Padovani A; Borroni B
    J Alzheimers Dis; 2013; 33(2):483-94. PubMed ID: 22986778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder.
    Cerami C; Marcone A; Galimberti D; Villa C; Scarpini E; Cappa SF
    J Alzheimers Dis; 2011; 27(4):791-7. PubMed ID: 21891869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease.
    Chitramuthu BP; Bennett HPJ; Bateman A
    Brain; 2017 Dec; 140(12):3081-3104. PubMed ID: 29053785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Loss-of-Function GRN Mutation p.(Tyr229*): Clinical and Neuropathological Features.
    Kuuluvainen L; Pöyhönen M; Pasanen P; Siitonen M; Rummukainen J; Tienari PJ; Paetau A; Myllykangas L
    J Alzheimers Dis; 2017; 55(3):1167-1174. PubMed ID: 27767988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autosomal Dominant Frontotemporal Lobar Degeneration in a Filipino Family with Progranulin Mutation.
    Dominguez J; Ng A; Yu J; Guevarra AC; Daroy ML; Alfon A; Catindig JA; Dizon M; Santiago J; Del Moral MC; Yu J; Jamerlan A; Ligsay A; Bagyinszky E; An SS; Kim S
    Dement Geriatr Cogn Disord; 2020; 49(6):557-564. PubMed ID: 33486486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study.
    Galimberti D; Fumagalli GG; Fenoglio C; Cioffi SMG; Arighi A; Serpente M; Borroni B; Padovani A; Tagliavini F; Masellis M; Tartaglia MC; van Swieten J; Meeter L; Graff C; de Mendonça A; Bocchetta M; Rohrer JD; Scarpini E;
    Neurobiol Aging; 2018 Feb; 62():245.e9-245.e12. PubMed ID: 29146050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study.
    Ghidoni R; Stoppani E; Rossi G; Piccoli E; Albertini V; Paterlini A; Glionna M; Pegoiani E; Agnati LF; Fenoglio C; Scarpini E; Galimberti D; Morbin M; Tagliavini F; Binetti G; Benussi L
    Neurodegener Dis; 2012; 9(3):121-7. PubMed ID: 22123177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia.
    Cerami C; Marcone A; Galimberti D; Villa C; Fenoglio C; Scarpini E; Cappa SF
    J Alzheimers Dis; 2013; 36(3):415-20. PubMed ID: 23624518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.